Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The prognostic utility of 18F-FDG PET parameters in lymphoma patients under CAR-T-cell therapy: a systematic review and meta-analysis.
Al-Ibraheem A, Abdlkadir AS, Al-Adhami DA, Sathekge M, Bom HH, Ma'koseh M, Mansour A, Abdel-Razeq H, Al-Rabi K, Estrada-Lobato E, Al-Hussaini M, Matalka I, Abdel Rahman Z, Fanti S. Al-Ibraheem A, et al. Among authors: abdel rahman z. Front Immunol. 2024 Sep 2;15:1424269. doi: 10.3389/fimmu.2024.1424269. eCollection 2024. Front Immunol. 2024. PMID: 39286245 Free PMC article.
Clinical Characteristics and Outcomes of CML in Adolescents and Young Adults.
Al-Rabi K, Ma'koseh M, Al-Qadi F, Hanoon AA, Da'na W, Asha AJ, Abdel Rahman Z, Marie L, Shahin O, Ma'koseh R, Al-Ibraheem A, Zayed A, Yaseen A, Al-Rabee S, Farfoura H, Abdel-Razeq H. Al-Rabi K, et al. Among authors: abdel rahman z. Clin Lymphoma Myeloma Leuk. 2024 Oct;24(10):715-723. doi: 10.1016/j.clml.2024.05.016. Epub 2024 May 25. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38918115
Intensity of Cancer Care Near the End of Life at a Tertiary Care Cancer Center in Jordan.
Abdel-Razeq H, Shamieh O, Abu-Nasser M, Nassar M, Samhouri Y, Abu-Qayas B, Asfour J, Jarrah J, Abdelrahman Z, Ameen Z, Al-Hawamdeh A, Alomari M, Al-Tabba' A, Al-Rimawi D, Hui D. Abdel-Razeq H, et al. J Pain Symptom Manage. 2019 Jun;57(6):1106-1113. doi: 10.1016/j.jpainsymman.2019.02.016. Epub 2019 Feb 23. J Pain Symptom Manage. 2019. PMID: 30802634 Free article.
Acute seizures and status epilepticus in immune effector cell associated neurotoxicity syndrome (ICANS).
Saw JL, Sidiqi MH, Ruff M, Hocker S, Alkhateeb H, Ansell SM, Bennani NN, Dingli D, Hayman SR, Johnston PB, Kapoor P, Kenderian SJ, Kourelis TV, Kumar SK, Paludo J, Shah MV, Siddiqui MA, Warsame R, Rosenthal A, Grill M, Castro JE, Siegel J, Abdel Rahman ZH, Kharfan-Dabaja MA, So E, Lin Y. Saw JL, et al. Among authors: abdel rahman zh. Blood Cancer J. 2022 Apr 13;12(4):62. doi: 10.1038/s41408-022-00657-x. Blood Cancer J. 2022. PMID: 35418113 Free PMC article. No abstract available.
Incidence of thrombosis in relapsed/refractory B-cell lymphoma treated with axicabtagene ciloleucel: Mayo Clinic experience.
Melody M, Gandhi S, Saunders H, Abdel-Rahman Z, Hastings J, Lengerke Diaz P, Gannon N, Truong T, Hathcock M, Khurana A, Johnston P, Ansell S, Bennani N, Paludo J, Bisneto JV, Wang Y, Rosenthal A, Foran J, Ayala E, Murthy HS, Roy V, Castro JE, Lin Y, Kharfan-Dabaja MA. Melody M, et al. Among authors: abdel rahman z. Leuk Lymphoma. 2022 Jun;63(6):1363-1368. doi: 10.1080/10428194.2022.2030475. Epub 2022 Feb 3. Leuk Lymphoma. 2022. PMID: 35109766
Gilteritinib clinical activity in relapsed/refractory FLT3 mutated acute myeloid leukemia previously treated with FLT3 inhibitors.
Numan Y, Abdel Rahman Z, Grenet J, Boisclair S, Bewersdorf JP, Collins C, Barth D, Fraga M, Bixby DL, Zeidan AM, Yilmaz M, Desai P, Mannis G, Deutsch YE, Abaza Y, Dinner S, Frankfurt O, Litzow M, Al-Kali A, Foran JM, Sproat LZ, Jovanovic B, Daver N, Perl AE, Altman JK. Numan Y, et al. Among authors: abdel rahman z. Am J Hematol. 2022 Mar 1;97(3):322-328. doi: 10.1002/ajh.26447. Epub 2022 Jan 7. Am J Hematol. 2022. PMID: 34981560 Free article. Clinical Trial.
Comparative study of therapy-related and de novo adult b-cell acute lymphoblastic leukaemia.
Abdel Rahman ZH, Parrondo RD, Heckman MG, Wieczorek M, Miller KC, Alkhateeb H, Sproat LZ, Murthy H, Hogan WJ, Kharfan-Dabaja MA, Peterson JF, Baughn LB, Hoppman N, Litzow MR, Ketterling RP, Greipp PT, Foran JM. Abdel Rahman ZH, et al. Br J Haematol. 2022 Feb;196(4):963-968. doi: 10.1111/bjh.17906. Epub 2021 Oct 25. Br J Haematol. 2022. PMID: 34697797 Free PMC article.
Identification of adult Philadelphia-like acute lymphoblastic leukemia using a FISH-based algorithm distinguishes prognostic groups and outcomes.
Abdel-Rahman ZH, Heckman MG, Anagnostou T, White LJ, Kloft-Nelson SM, Knudson RA, Alkhateeb HB, Sproat LZ, Khera N, Murthy HS, Ayala E, Hogan WJ, Roy V, Peterson JF, Kharfan-Dabaja MA, Ketterling RP, Litzow MR, Baughn LB, Patnaik M, Greipp PT, Foran JM. Abdel-Rahman ZH, et al. Blood Cancer J. 2021 Sep 21;11(9):156. doi: 10.1038/s41408-021-00538-9. Blood Cancer J. 2021. PMID: 34548472 Free PMC article. No abstract available.
Impact of Novel Targeted Therapies and Cytogenetic Risk Groups on Outcome After Allogeneic Transplantation for Adult ALL.
Abdel Rahman ZH, Heckman MG, Miller K, Alkhateeb H, Patnaik MS, Sproat LZ, Jiang L, Roy V, Murthy HS, Ayala E, Hogan WJ, Greipp PT, Kharfan-Dabaja MA, Litzow MR, Foran JM. Abdel Rahman ZH, et al. Transplant Cell Ther. 2021 Feb;27(2):165.e1-165.e11. doi: 10.1016/j.jtct.2020.10.015. Epub 2020 Dec 11. Transplant Cell Ther. 2021. PMID: 33830026 Free article.
19 results